Effect of Intraoperative Crystalloid Volume on Postoperative Vomiting
NCT ID: NCT02177201
Last Updated: 2016-02-01
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
160 participants
INTERVENTIONAL
2013-08-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of POV After Paediatric Tonsillectomy
NCT02387918
Ultrasound Evaluation of Gastric Volume in Pediatric Patients Undergoing Adenotonsillectomy Surgery
NCT05734937
Effect of Pre-operative Oral Hydration on Post-operative Pain and Nausea in Adults Undergoing Tonsillectomy
NCT05507918
Postoperative Nausea and Vomiting and Acupuncture/Acupressure
NCT00965367
Dexamethasone Versus Local Infiltration Technique for Tonsillectomy in Children
NCT02355678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
intravenous administration of 10 ml/kg/h 0.9% saline solution
Group 1
Intravenous access was established and 10 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.
Group 2
intravenous administration of 20 ml/kg/h 0.9% saline solution
Group 2
Intravenous access was established and 20 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1
Intravenous access was established and 10 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.
Group 2
Intravenous access was established and 20 ml/kg/h 0.9% saline solution was delivered following the induction of anesthesia and until the end of the operation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Scheduled for elective tonsillectomy and/or adenotonsillectomy
Exclusion Criteria
* History of mental retardation
* Obesity (BMI = \> 95th percentile for age and sex)
* Intake of antiemetic or psychoactive medication within 24 hours before surgery
* Known gastroesophageal reflux
2 Years
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aydin Adnan Menderes University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
SİNAN YILMAZ
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
SİNAN YILMAZ, MD
Role: STUDY_DIRECTOR
Adnan Menderes University,Faculty of Medicine, Department of Anesthesia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adnan Menderes University Training and Research Hospital
Aydin, Aydın, Turkey (Türkiye)
Adnan Menders University
Aydin, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013/255
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.